Unrelated Cord Blood Stem Cell Transplantation Using Non-Myeloablative Regimen for Refractory Non-Hodgkin's Lymphoma

We have performed an allogeneic umbilical cord blood stem cell transplant to an 12-year-old male patient with T-cell Non-Hodgkin's lymphoma (NHL). The NHL was refractory to conventional intensive chemotherapy. High-dose chemotherapy and radiation therapy was given, but the patient relapsed 3 ti...

Full description

Saved in:
Bibliographic Details
Published inThe Japanese Journal of Pediatric Hematology Vol. 18; no. 6; pp. 609 - 613
Main Authors OHTSUKI, Fumiko, YAMAMOTO, Masuji, TANIZAWA, Takakuni, TAKEDA, Hiroki, MORITA, Naoko, KANEDA, Yumi, OHTSUKA, Yoshitoshi, ASANO, Yumi
Format Journal Article
LanguageJapanese
Published THE JAPANESE SOCIETY OF PEDIATRIC HEMATOLOGY/ONCOLOGY 2004
特定非営利活動法人 日本小児血液・がん学会
Subjects
Online AccessGet full text
ISSN0913-8706
1884-4723
DOI10.11412/jjph1987.18.6_609

Cover

Abstract We have performed an allogeneic umbilical cord blood stem cell transplant to an 12-year-old male patient with T-cell Non-Hodgkin's lymphoma (NHL). The NHL was refractory to conventional intensive chemotherapy. High-dose chemotherapy and radiation therapy was given, but the patient relapsed 3 times. He was then treated with allogeneic umbilical cord blood stem cell transplantation (CBSCT) using a fludarabine, and melphalan-based nonmyeloablative conditioning regimen. GVHD prophylaxis was composed of tacrolimus alone. The patient had neutrophil engraftment within 28 days. Investigation by short tandem repeat (STR) showed that 100% of his bone marrow nucleated cells were reconstituted by donor origin since day +28. He is now alive and well and remains disease-free 7 months after transplant. Although the symptom of GVHD is faint, we evaluated that the graft-versus-lymphoma effect is one of the factors contributing to his remission.
AbstractList We have performed an allogeneic umbilical cord blood stem cell transplant to an 12-year-old male patient with T-cell Non-Hodgkin's lymphoma (NHL). The NHL was refractory to conventional intensive chemotherapy. High-dose chemotherapy and radiation therapy was given, but the patient relapsed 3 times. He was then treated with allogeneic umbilical cord blood stem cell transplantation (CBSCT) using a fludarabine, and melphalan-based nonmyeloablative conditioning regimen. GVHD prophylaxis was composed of tacrolimus alone. The patient had neutrophil engraftment within 28 days. Investigation by short tandem repeat (STR) showed that 100% of his bone marrow nucleated cells were reconstituted by donor origin since day +28. He is now alive and well and remains disease-free 7 months after transplant. Although the symptom of GVHD is faint, we evaluated that the graft-versus-lymphoma effect is one of the factors contributing to his remission.
We have performed an allogeneic umbilical cord blood stem cell transplant to an 12-year-old male patient with T-cell Non-Hodgkin's lymphoma (NHL). The NHL was refractory to conventional intensive chemotherapy. High-dose chemotherapy and radiation therapy was given, but the patient relapsed 3 times. He was then treated with allogeneic umbilical cord blood stem cell transplantation (CBSCT) using a fludarabine, and melphalan-based nonmyeloablative conditioning regimen. GVHD prophylaxis was composed of tacrolimus alone. The patient had neutrophil engraftment within 28 days. Investigation by short tandem repeat (STR) showed that 100% of his bone marrow nucleated cells were reconstituted by donor origin since day +28. He is now alive and well and remains disease-free 7 months after transplant. Although the symptom of GVHD is faint, we evaluated that the graft-versus-lymphoma effect is one of the factors contributing to his remission. 頻回再発した非ポジキンリンパ腫 (NHL) に対して骨髄非破壊性前処置を用いて臍帯血移植を施行した1例を報告する.症例は12歳男児.11歳時にT細胞性非ポジキンリンパ腫を発症, JACLS NHL-98プロトコールにていったん寛解を得た.しかし, 維持療法中に中枢神経再発したため再入院し, 化学療法・放射線療法を施行するも計3回の再発を認めた.造血幹細胞移植による治療を計画したが, HLA一致同胞が存在せず, 緊急性があったために移植ソースに同種臍帯血を選択した.また, 度重なる治療による臓器毒性を考慮し, 移植前処置は骨髄非破壊性前処置とした.移植後明らかな臓器毒性, 重症感染やGVHD症状を認めず, 現在寛解を維持している.骨髄非破壊性前処置を用いた造血幹細胞移植のソースとして同種末梢血幹細胞や同種骨髄幹細胞を選択されることが多いが, 同種臍帯血も十分使用可能と考えられた.
Author OHTSUKA, Yoshitoshi
KANEDA, Yumi
MORITA, Naoko
TAKEDA, Hiroki
ASANO, Yumi
OHTSUKI, Fumiko
TANIZAWA, Takakuni
YAMAMOTO, Masuji
Author_FL 森田 直子
浅野 由美
大塚 欣敏
大槻 史子
谷澤 隆邦
金田 由美
竹田 洋樹
山本 益嗣
Author_FL_xml – sequence: 1
  fullname: 竹田 洋樹
– sequence: 2
  fullname: 山本 益嗣
– sequence: 3
  fullname: 大塚 欣敏
– sequence: 4
  fullname: 大槻 史子
– sequence: 5
  fullname: 森田 直子
– sequence: 6
  fullname: 浅野 由美
– sequence: 7
  fullname: 金田 由美
– sequence: 8
  fullname: 谷澤 隆邦
Author_xml – sequence: 1
  fullname: OHTSUKI, Fumiko
  organization: Department of Pediatrics, Hyogo College of Medicine
– sequence: 1
  fullname: YAMAMOTO, Masuji
  organization: Department of Pediatrics, Hyogo College of Medicine
– sequence: 1
  fullname: TANIZAWA, Takakuni
  organization: Department of Pediatrics, Hyogo College of Medicine
– sequence: 1
  fullname: TAKEDA, Hiroki
  organization: Department of Pediatrics, Hyogo College of Medicine
– sequence: 1
  fullname: MORITA, Naoko
  organization: Department of Pediatrics, Hyogo College of Medicine
– sequence: 1
  fullname: KANEDA, Yumi
  organization: Department of Pediatrics, Hyogo College of Medicine
– sequence: 1
  fullname: OHTSUKA, Yoshitoshi
  organization: Department of Pediatrics, Hyogo College of Medicine
– sequence: 1
  fullname: ASANO, Yumi
  organization: Department of Pediatrics, Hyogo College of Medicine
BackLink https://cir.nii.ac.jp/crid/1390001204343021440$$DView record in CiNii
BookMark eNo9kE9PwzAMxSMEEmPsC3DKAYlTh9OkbXqE8WdIAyTYzlXaOl1Km1RphdRvT2GALD1b9u_58M7IsXUWCblgsGRMsPC6rrs9S2WyZHIZZzGkR2TGpBSBSEJ-TGaQMh7IBOJTsuh7kwNEUgKIZEaGnfXYqAFLunK-pLeNcyV9H7ClK2wauvXK9l2j7KAG4yzd9cZW9MXZ4HnExql88ppPpG9YmRYt1c5Ps_aqGJwff8C1K6sPY696uhnbbu9adU5OtGp6XPz2Odk93G9X62Dz-vi0utkENRMJBLGAKA81cmRKCJ3nZRGnMspLJgpdppAiE1jyaRWB1hKn0hHncZzINOS54nNyefhrjckK862MpwDAQhBccAiZEDBhdwes7gdVYdZ50yo_ZsoPpmgw-4s3YzKLDzJl_H8u9spnaPkX1u54cQ
ContentType Journal Article
Copyright Copyright Clearance Center, Inc
Copyright_xml – notice: Copyright Clearance Center, Inc
DBID RYH
DOI 10.11412/jjph1987.18.6_609
DatabaseName CiNii Complete
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate 骨髄非破壊性前処置を用いてさい帯血移植を施行した頻回再発非ホジキンリンパ腫の1例
DocumentTitle_FL 骨髄非破壊性前処置を用いてさい帯血移植を施行した頻回再発非ホジキンリンパ腫の1例
EISSN 1884-4723
EndPage 613
ExternalDocumentID 130004345843
article_jjph1987_18_6_18_6_609_article_char_en
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
JSF
KQ8
RJT
RYH
ID FETCH-LOGICAL-j1470-6405b2fe3e1a44fbbdc6985bd14cfd909e14ed398550ff8e8e8f5336678923ba3
ISSN 0913-8706
IngestDate Thu Jun 26 21:33:54 EDT 2025
Wed Sep 03 06:30:01 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 6
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j1470-6405b2fe3e1a44fbbdc6985bd14cfd909e14ed398550ff8e8e8f5336678923ba3
OpenAccessLink https://www.jstage.jst.go.jp/article/jjph1987/18/6/18_6_609/_article/-char/en
PageCount 5
ParticipantIDs nii_cinii_1390001204343021440
jstage_primary_article_jjph1987_18_6_18_6_609_article_char_en
PublicationCentury 2000
PublicationDate 2004
PublicationDateYYYYMMDD 2004-01-01
PublicationDate_xml – year: 2004
  text: 2004
PublicationDecade 2000
PublicationTitle The Japanese Journal of Pediatric Hematology
PublicationTitleAlternate J.J.P.H.
PublicationTitle_FL 日本小児血液学会雑誌
J.J.P.H
日小血会誌
PublicationYear 2004
Publisher THE JAPANESE SOCIETY OF PEDIATRIC HEMATOLOGY/ONCOLOGY
特定非営利活動法人 日本小児血液・がん学会
Publisher_xml – name: THE JAPANESE SOCIETY OF PEDIATRIC HEMATOLOGY/ONCOLOGY
– name: 特定非営利活動法人 日本小児血液・がん学会
References 7) Miyakoshi S, Yuji K, Kami M, et al : Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases. Clin Cancer Res 10 : 3586-3592, 2004
3) Michallet M, Bilger K, Garban F, et al : Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens : Impact of pretransplantation and posttransplantation factors on outcome. J Clin Oncol 19 : 3340-3349, 2001
1) Slavin S, Nagler A, Naparstek E, et al : Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and non malignant hematologic diseases. Blood 91 : 756-763, 1998
2) Childs R, Clave E, Contentin N, et al : Engraftment kinetics after non-myeloablative allogeneic peripheral blood stem cell transplantation : Full donor T-cell chimerism precedes alloimmune responses. Blood 94 : 3234-3241, 1999
4) Yazaki M, Takahashi T, Ito Y, et al : Generation of HLAA2 subtype specific cytotoxic T lymphocytes from cord blood used for cord blood stem cell transplantation. Bone Marrow Transplant 26 : 451-453, 2000
6) Khee WH, Chye PT, Hoe TC, et al : Autologous recovery with protractedly undetectable donor chimerisms can precede stable donor engraftment in a nonmyeloablative cord blood transplant. Int J Hematol 78 : 73-75, 2003
5) Rizzieri DA, Long GD, Vredenburgh JJ, et al : Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen. Blood 98 : 3486-3488, 2001
References_xml – reference: 4) Yazaki M, Takahashi T, Ito Y, et al : Generation of HLAA2 subtype specific cytotoxic T lymphocytes from cord blood used for cord blood stem cell transplantation. Bone Marrow Transplant 26 : 451-453, 2000
– reference: 1) Slavin S, Nagler A, Naparstek E, et al : Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and non malignant hematologic diseases. Blood 91 : 756-763, 1998
– reference: 5) Rizzieri DA, Long GD, Vredenburgh JJ, et al : Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen. Blood 98 : 3486-3488, 2001
– reference: 3) Michallet M, Bilger K, Garban F, et al : Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens : Impact of pretransplantation and posttransplantation factors on outcome. J Clin Oncol 19 : 3340-3349, 2001
– reference: 2) Childs R, Clave E, Contentin N, et al : Engraftment kinetics after non-myeloablative allogeneic peripheral blood stem cell transplantation : Full donor T-cell chimerism precedes alloimmune responses. Blood 94 : 3234-3241, 1999
– reference: 6) Khee WH, Chye PT, Hoe TC, et al : Autologous recovery with protractedly undetectable donor chimerisms can precede stable donor engraftment in a nonmyeloablative cord blood transplant. Int J Hematol 78 : 73-75, 2003
– reference: 7) Miyakoshi S, Yuji K, Kami M, et al : Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases. Clin Cancer Res 10 : 3586-3592, 2004
SSID ssib005880047
ssj0003236711
ssib053390765
ssib002003923
ssib058493933
Score 1.5999771
Snippet We have performed an allogeneic umbilical cord blood stem cell transplant to an 12-year-old male patient with T-cell Non-Hodgkin's lymphoma (NHL). The NHL was...
SourceID nii
jstage
SourceType Publisher
StartPage 609
SubjectTerms cord blood stem cell transplantation
non-Hodgkin's lymphoma
non-myeloablative regimen
Title Unrelated Cord Blood Stem Cell Transplantation Using Non-Myeloablative Regimen for Refractory Non-Hodgkin's Lymphoma
URI https://www.jstage.jst.go.jp/article/jjph1987/18/6/18_6_609/_article/-char/en
https://cir.nii.ac.jp/crid/1390001204343021440
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX The Japanese Journal of Pediatric Hematology, 2004/12/31, Vol.18(6), pp.609-613
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEF6l5cIFgQBRoGgPSBwqF2-89ePAwaRGSUuS0jqicLH82C12WrtKk0P470jM7DqO23CgoEiryC_ZM59mvp2dmSXkbWp5rgQ_aKRZkhg8dZgRp1lsWFYKDpaxmJlY7zwc2f0JPzo_OO90frWylhbzZD_9-ce6kn_RKhwDvWKV7D002zwUDsB_0C-MoGEY_0rHk1KVomCQFqv-PmISOuZtXe31MCSnG5dfxmWdUajTA0ZVaQyX4rKKk0vd9ftUXGCPf5VxeCrkTG3Bs1QX9qvsQm3Y5dzsfV6C5qvajhdrlB2Bv8V9LPda5LbZAQT8GnDiW7H7cT88mxwPFG1eXOXTqrE84ACG43Csa4huFkXexBX80eC7_9VX6Iqn8XRRts4dB4fqTD-fVdP8VhxjHcHE1KYj_8QfBWcB9n8YBOE3THk6CQ4HfngKYOwHQz9U62qgkfGot15iq0OZzDJwvVb7NG3IXZcb3NG1zJuW_o7Ztk2vxQBsXR276Vw4w261RXH9A0M1-8zdt6Pm1ltNu2tIRKtrI-ZGth7ghmh1GivrAMhb5EHXcRhmpB5_ac3-sHC6xd4OwNa2FkmBqHums16kBirpWV7N3pGIWNidT-1A3UhoVTYGX_J-4zuAhBUwJcFeE1tlnrd4VviYPKoxRH397k9Ip4ifknmDdIpIpwrpFJFOEen0DtKpQjrdQDqtkU4B6XSNdNpC-rsbusL5MzL5FIS9vlHvF2IUjDumYcPkI-lKYQkWcy6TJEttzz1IMsZTmXmmJxgXGRgnmJVL6Qr4SRCiDXwNxJzE1nOyXValeEGoE8eWJbyu7GaCe2YCNNhigkvJJUjZdnbIBy2q6Fo3hYnup_EdsgsSjtIcR5iEqYCwiVXeqoeh-fI_n_-KPNQpZhgrfE2257OF2AX2PE_eKIz9BlLYv6o
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Unrelated+Cord+Blood+Stem+Cell+Transplantation+Using+Non-Myeloablative+Regimen+for+Refractory+Non-Hodgkin%27s+Lymphoma&rft.jtitle=The+Japanese+Journal+of+Pediatric+Hematology&rft.au=OHTSUKI%2C+Fumiko&rft.au=YAMAMOTO%2C+Masuji&rft.au=TANIZAWA%2C+Takakuni&rft.au=TAKEDA%2C+Hiroki&rft.date=2004&rft.pub=THE+JAPANESE+SOCIETY+OF+PEDIATRIC+HEMATOLOGY%2FONCOLOGY&rft.issn=0913-8706&rft.eissn=1884-4723&rft.volume=18&rft.issue=6&rft.spage=609&rft.epage=613&rft_id=info:doi/10.11412%2Fjjph1987.18.6_609&rft.externalDocID=article_jjph1987_18_6_18_6_609_article_char_en
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0913-8706&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0913-8706&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0913-8706&client=summon